Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease.
Maximal treadmill testing was carried out in 50 patients with angiographically documented coronary artery disease (CAD) in the presence and absence of beta-adrenoceptor blockade. The results were related to the extent of CAD and interpreted relative to the clinical value of exercise testing. Maximal heart rate and systolic blood pressure were significantly lower during treatment with beta-blocking drugs. The average exercise duration was 1.3 +/- 1.9 minutes greater (+/- standard deviation), regardless of coronary anatomy. Of the 20 subjects with 3-vessel or left main CAD (severe CAD), 8 patients completed 3 stages (9 minutes) of exercise during treatment; only 4 did so without treatment. Angina was significantly more often the limiting symptom with severe CAD, and this association was abolished by beta blockade; 1 of 20 with severe CAD completed 3 stages of exercise and was not limited by angina without beta-blocking treatment, whereas 7 had these features during beta-blockade therapy. Maximal ST-segment depression was not related to the extent of CAD with or without therapy. Beta blockade suppressed the occurrence of ST depression, or delayed its appearance by an average of 2.0 +/- 2.3 minutes and reduced its severity by 0.5 +/- 0.9 mm. All tests in which ST depression was completely suppressed were associated with inadequate heart rate response, regarded as diagnostically inconclusive rather than negative. However, during beta-blocking treatment, 14 tests (28%) were inconclusive, which, in routine practice, would have necessitated repeat testing.(ABSTRACT TRUNCATED AT 250 WORDS)
Ho
S W
SW
McComish
M J
MJ
Taylor
R R
RR
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000209:etiology; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D004562:Electrocardiography; D005080:Exercise Test / Q000009:adverse effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000319:Adrenergic beta-Antagonists